Back

Endocavitary injection of bone-marrow-derived CD133+ cells in ischemic REfractory CARDIOmyopathy (RECARDIO trial)

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters 5 - Best Posters in stem cells Stem cells and cell therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Stefano Righetti

San Gerardo Vecchio Hospital, Monza (Italy)

4 More presentations in this session

Presentation thumbnail
Discussant: Best Posters in stem cells
Presentation thumbnail
Bradykinin inhibits High Glucose-Induced Senescence of c-kit Positive Cardiac Stem Cells via B2R/PI3K/AKT/mTOR/P53 signal pathway
Doctor C. Fu (Wuhu, CN)
Abstract Slides
Presentation thumbnail
Activation of the calcineurin-NFAT pathway in hypertrophic cardiomyopathy due to abnormal calcium homeostasis contributes to progression of cardiomyocytes hypertrophy: Insights from human iPSC model
Miss X. Ran (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Transcoronary cardiac progenitors in patients with functional single ventricle: two-year follow-up of the phase 1/2 clinical trials
Doctor T. Sano (San Francisco, US)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 5 - Best Posters in stem cells

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources